156 related articles for article (PubMed ID: 12382026)
1. Serum glutathione-S-transferase and glutathione reductase activity in head and neck cancer patients.
Patel BP; Raval GN; Rawal RM; Patel JB; Sainger RN; Patel MM; Shah MH; Patel DD; Patel PS
Neoplasma; 2002; 49(4):260-6. PubMed ID: 12382026
[TBL] [Abstract][Full Text] [Related]
2. Study of tobacco habits and alterations in enzymatic antioxidant system in oral cancer.
Patel BP; Rawal UM; Shah PM; Prajapati JA; Rawal RM; Dave TK; Patel PS
Oncology; 2005; 68(4-6):511-9. PubMed ID: 16037684
[TBL] [Abstract][Full Text] [Related]
3. The association between glutathione S-transferase P1 genotype and plasma level in head and neck cancer.
Kelders WP; Oude Ophuis MB; Roelofs HM; Peters WH; Manni JJ
Laryngoscope; 2002 Mar; 112(3):462-6. PubMed ID: 12148855
[TBL] [Abstract][Full Text] [Related]
4. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
5. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
Patel PS; Shah MH; Jha FP; Raval GN; Rawal RM; Patel MM; Patel JB; Patel DD
Indian J Cancer; 2004; 41(1):25-31. PubMed ID: 15105576
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide and antioxidant enzymes in the pathogenesis of oral cancer.
Patel JB; Shah FD; Shukla SN; Shah PM; Patel PS
J Cancer Res Ther; 2009; 5(4):247-53. PubMed ID: 20160357
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
8. Plasma glutathione S-transferase P1-1 levels in patients with head and neck squamous cell carcinoma.
Oude Ophuis MB; Mulder TP; Peters WH; Manni JJ
Cancer; 1998 Jun; 82(12):2434-8. PubMed ID: 9635537
[TBL] [Abstract][Full Text] [Related]
9. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
10. Tobacco, antioxidant enzymes, oxidative stress, and genetic susceptibility in oral cancer.
Patel BP; Rawal UM; Rawal RM; Shukla SN; Patel PS
Am J Clin Oncol; 2008 Oct; 31(5):454-9. PubMed ID: 18838881
[TBL] [Abstract][Full Text] [Related]
11. Genotype and phenotype of glutathione-S-transferase in patients with head and neck carcinoma.
Konig-Greger D; Riechelmann H; Wittich U; Gronau S
Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15195058
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase pi in squamous cell carcinoma of the head and neck.
Bentz BG; Haines GK; Radosevich JA
Laryngoscope; 2000 Oct; 110(10 Pt 1):1642-7. PubMed ID: 11037818
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas.
Wang X; Pavelic ZP; Li Y; Gleich L; Gartside PS; Pavelic L; Gluckman JL; Stambrook PJ
Clin Cancer Res; 1997 Jan; 3(1):111-4. PubMed ID: 9815545
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
15. Glutathione, glutathione reductase and glutathione S-transferase activities in erythrocytes and lymphocytes in chronic renal disease.
El-Rashidy FH; Al-Turk WA; Stohs SJ
Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):423-30. PubMed ID: 6463365
[TBL] [Abstract][Full Text] [Related]
16. Altered antioxidant capacity in human renal cell carcinoma: role of glutathione associated enzymes.
Pljesa-Ercegovac M; Mimic-Oka J; Dragicevic D; Savic-Radojevic A; Opacic M; Pljesa S; Radosavljevic R; Simic T
Urol Oncol; 2008; 26(2):175-81. PubMed ID: 18312938
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein electrophoretic pattern in sera of patients with oral precancerous conditions and upper aerodigestive tract cancer.
Patel PS; Rawal RM; Raval GN; Patel BP; Patel YV; Shah SG; Balar DB; Patel DD
J Exp Clin Cancer Res; 1997 Mar; 16(1):65-70. PubMed ID: 9148863
[TBL] [Abstract][Full Text] [Related]
18. Assessment of glutathione-S-transferase and glutathione reductase in patients with squamous-cell carcinoma of buccal mucosa.
Rawal RM; Patel DD; Patel BP; Patel MM; Wadhwa MK; Patel PS; Bhatavdekar JM
Int J Cancer; 1999 Dec; 83(6):727-31. PubMed ID: 10597186
[TBL] [Abstract][Full Text] [Related]
19. Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer.
Ghalia AA; Rabboh NA; el Shalakani A; Seada L; Khalifa A
Anticancer Res; 2000; 20(2B):1229-35. PubMed ID: 10810426
[TBL] [Abstract][Full Text] [Related]
20. Glutathione-linked enzymes in benign and malignant oesophageal tissue.
Levy RD; Oosthuizen MM; Degiannis E; Greyling D; Hatzitheofilou C
Br J Cancer; 1999 Apr; 80(1-2):32-7. PubMed ID: 10389974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
